1013 related articles for article (PubMed ID: 2137024)
1. Protection of spermatogenesis in rats from the cytotoxic procarbazine by the depot formulation of Zoladex, a gonadotropin-releasing hormone agonist.
Ward JA; Robinson J; Furr BJ; Shalet SM; Morris ID
Cancer Res; 1990 Feb; 50(3):568-74. PubMed ID: 2137024
[TBL] [Abstract][Full Text] [Related]
2. Partial prevention of procarbazine induced germinal cell aplasia in rats by sequential GnRH antagonist and testosterone administration.
Pogach LM; Lee Y; Gould S; Giglio W; Huang HF
Cancer Res; 1988 Aug; 48(15):4354-60. PubMed ID: 3134124
[TBL] [Abstract][Full Text] [Related]
3. Rat prostatic weight regression in reaction to ketoconazole, cyproterone acetate, and RU 23908 as adjuncts to a depot formulation of gonadotropin-releasing hormone analogue.
Lamberts SW; Uitterlinden P; de Jong FH
Cancer Res; 1988 Nov; 48(21):6063-8. PubMed ID: 2844399
[TBL] [Abstract][Full Text] [Related]
4. Protection by steroid contraceptives against procarbazine-induced sterility and genotoxicity in male rats.
Velez de la Calle JF; Jégou B
Cancer Res; 1990 Feb; 50(4):1308-15. PubMed ID: 2137028
[TBL] [Abstract][Full Text] [Related]
5. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
6. Prolonged suppression of rat testis function by a depot formulation of Zoladex, a GnRH agonist.
Ward JA; Furr BJ; Valcaccia B; Curry B; Bardin CW; Gunsalus GL; Morris ID
J Androl; 1989; 10(6):478-86. PubMed ID: 2533593
[TBL] [Abstract][Full Text] [Related]
7. Protection against procarbazine-induced testicular damage by GnRH-agonist and antiandrogen treatment in the rat.
Kangasniemi M; Wilson G; Huhtaniemi I; Meistrich ML
Endocrinology; 1995 Aug; 136(8):3677-80. PubMed ID: 7628410
[TBL] [Abstract][Full Text] [Related]
8. Hormone treatment after irradiation stimulates recovery of rat spermatogenesis from surviving spermatogonia.
Meistrich ML; Kangasniemi M
J Androl; 1997; 18(1):80-7. PubMed ID: 9089071
[TBL] [Abstract][Full Text] [Related]
9. [Chemical castration using a depot LHRH-agonist as a palliative therapy concept in prostatic carcinoma--clinical, endocrinological and experimental studies].
Kuber W; Treu T; Kratzik C; Girsch E; Zeillinger R; Spona J
Wien Klin Wochenschr; 1990 Nov; 102(21):640-7. PubMed ID: 2148044
[TBL] [Abstract][Full Text] [Related]
10. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
Behre HM; Nashan D; Hubert W; Nieschlag E
J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
[TBL] [Abstract][Full Text] [Related]
11. Effects of the gonadotrophin-releasing hormone agonist 'Zoladex' upon pituitary and gonadal function in hypogonadal (hpg) male mice: a comparison with normal male and testicular feminized (tfm) mice.
Scott IS; Bennett MK; Porter-Goff AE; Harrison CJ; Cox BS; Grocock CA; O'Shaughnessy PJ; Clayton RN; Craven R; Furr BJ
J Mol Endocrinol; 1992 Jun; 8(3):249-58. PubMed ID: 1385960
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of triptolide on spermatogenesis, epididymal sperm function, and fertility in male rats.
Huynh PN; Hikim AP; Wang C; Stefonovic K; Lue YH; Leung A; Atienza V; Baravarian S; Reutrakul V; Swerdloff RS
J Androl; 2000; 21(5):689-99. PubMed ID: 10975416
[TBL] [Abstract][Full Text] [Related]
13. Prolonged suppression of spermatogenesis by oestrogen does not preserve the seminiferous epithelium in procarbazine-treated rats.
Morris ID; Bardin CW; Gunsalus G; Ward JA
Int J Androl; 1990 Jun; 13(3):180-9. PubMed ID: 2117584
[TBL] [Abstract][Full Text] [Related]
14. Luteinizing hormone receptor-mediated effects on initiation of spermatogenesis in gonadotropin-deficient (hpg) mice are replicated by testosterone.
Spaliviero JA; Jimenez M; Allan CM; Handelsman DJ
Biol Reprod; 2004 Jan; 70(1):32-8. PubMed ID: 12954730
[TBL] [Abstract][Full Text] [Related]
15. Protection from procarbazine-induced damage of spermatogenesis in the rat by androgen.
Delic JI; Bush C; Peckham MJ
Cancer Res; 1986 Apr; 46(4 Pt 2):1909-14. PubMed ID: 3081260
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of analogs of luteinizing hormone-releasing hormone against chemotherapy-induced testicular damage in rats.
Karashima T; Zalatnai A; Schally AV
Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2329-33. PubMed ID: 2965391
[TBL] [Abstract][Full Text] [Related]
17. Antifertility effects of luteinizing hormone-releasing hormone (LHRH) agonists.
Labrie F; Bélanger A; Kelly PA; Séguin C; Cusan L; Lefebvre FA; Reeves JJ; Lemay A; Faure N; Gourdeau Y; Raynaud JP
Prog Clin Biol Res; 1981; 74():273-91. PubMed ID: 6275404
[TBL] [Abstract][Full Text] [Related]
18. Absence of testicular protection by a gonadotropin-releasing hormone analogue against cyclophosphamide-induced testicular cytotoxicity in the mouse.
da Cunha MF; Meistrich ML; Nader S
Cancer Res; 1987 Feb; 47(4):1093-7. PubMed ID: 3542201
[TBL] [Abstract][Full Text] [Related]
19. The effects of chronic administration of pyrimethamine on spermatogenesis and fertility in male rats.
Awoniyi CA; Chandrashekar V; Hurst BS; Kim WK; Schlaff WD
J Androl; 1993; 14(3):174-9. PubMed ID: 8407572
[TBL] [Abstract][Full Text] [Related]
20. Testicular function after local injection of 6-hydroxydopamine or norepinephrine in the golden hamster (Mesocricetus auratus).
Mayerhofer A; Amador AG; Steger RW; Bartke A
J Androl; 1990; 11(3):301-11. PubMed ID: 2117002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
